MGLVX | RWIHX | MGLVX / RWIHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 9 years | - |
Gain YTD | 13.076 | 13.299 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 437M | 125B | 0% |
Annual Yield % from dividends | 1.78 | 1.86 | 95% |
Returns for 1 year | 18.14 | 19.34 | 94% |
Returns for 3 years | -4.27 | 3.63 | -117% |
Returns for 5 years | 13.81 | 39.56 | 35% |
Returns for 10 years | 37.50 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WFEAX | 12.53 | -0.06 | -0.48% |
Allspring International Equity A | |||
LQFLX | 13.62 | -0.09 | -0.66% |
Lord Abbett Focused Large Cap Value R3 | |||
PJFOX | 71.43 | -1.62 | -2.22% |
PGIM Jennison Growth R2 | |||
PLXGX | 24.63 | -0.58 | -2.30% |
Virtus KAR Capital Growth I | |||
FBTIX | 32.77 | -1.67 | -4.85% |
Fidelity Advisor Biotechnology I |